Brain drug tested at home for genetic condition
NCT ID NCT06334419
Summary
This study tested a single dose of an experimental drug called gaboxadol in 10 adult men with Fragile X Syndrome, a genetic condition that causes intellectual disability. The main goal was to see how the drug affects brain wave patterns measured by a special cap (EEG). Researchers also wanted to find out if they could reliably conduct parts of the study, like brain recordings and eye-tracking tests, in participants' homes instead of just in a clinic.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRAGILE X SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
Conditions
Explore the condition pages connected to this study.